AneuVysion™ Prenatal FISH (13, 18, 21, X, Y) [FDA Approved]

Indications For AneuVysion™ Prenatal FISH (13, 18, 21, X, Y) 

  • Abnormal NIPT / Cell-free DNA
  • Advanced maternal age (>35 years of age)
  • Previous pregnancy with chromosomal abnormality
  • Recurrent spontaneous miscarriage
  • Family history of a chromosomal abnormality
  • Abnormal maternal serum screening results
  • Abnormal ultrasound findings

STAT 24-hour detection of aneuploidy for chromosomes 13, 18, 21, X & Y, via fluorescence in situ hybridization (FISH) assay in interphase cells from prenatal samples.  All FISH analysis is confirmed by routine cytogenetic analysis.

Collection Procedure

  • Amniotic fluid Discard the first 2 ml of fluid to reduce the risk of maternal cell contamination.  Aseptically transfer the specimen into sterile plastic conical tubes labeled with patient’s name and date of birth.
  •   CVS Aseptically transfer the specimen into sterile plastic conical tubes containing sterile transport medium (provided by CytoGenX). Label tube with patient’s name and date of birth.

A completed test requisition form must be included with every sample.  A transport kit is available upon request.

Specimen Requirements
3- 5 cc of amniotic fluid or 3 mg of CVS is used for FISH analysis (this is in addition to the normal amount collected for chromosome analysis).  This is not a standalone test and must be ordered with standard cytogenetic analysis.

Specimen Container
Sterile 15ml screw-cap container

Methodology
Fluorescence in situ hybridization is performed on interphase cells to detect aneuploidy of chromosomes 13, 18, 21, X & Y.  Results are confirmed by cytogenetic analysis.

Transport Temperature
Room temperature (DO NOT refrigerate, freeze or centrifuge)

Causes for Rejection
Frozen specimen, large amount of blood, inappropriate container

Turnaround Time
24 -hrs

For more information about Fluorescent in Situ Hybridization, please contact CytoGenx.